Page last updated: 2024-09-05

erlotinib hydrochloride and Paralysis

erlotinib hydrochloride has been researched along with Paralysis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bosch-Barrera, J; Guerra Prió, S; Hernández Martínez, A; Izquierdo Font, A; López Brunsó, M; Mas Pueyo, HG; Roa García, D; Sais Girona, E; Toro Blanch, C	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Paralysis

Article	Year
Probable drug-drug interaction between erlotinib and amiodarone causes severe neurotoxicity in a patient with advanced lung cancer. Anti-cancer drugs, 2018, Volume: 29, Issue:4 Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Drug Interactions; Erlotinib Hydrochloride; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Paralysis; Radiotherapy; Withholding Treatment	2018

Article

Year

Probable drug-drug interaction between erlotinib and amiodarone causes severe neurotoxicity in a patient with advanced lung cancer.

Anti-cancer drugs, 2018, Volume: 29, Issue:4

Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Drug Interactions; Erlotinib Hydrochloride; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Middle Aged; Paralysis; Radiotherapy; Withholding Treatment

2018